Постановление Правительства Республики Бурятия от 06.06.2014 № 263

| 2.8   | Число больных                | число больных          |   2,80 | 3,75   | 4,70   | 5,65   | 6,60   | 7,55    | 8,50   | 9,45   | 10,40   |
|       | алкоголизмом, находящихся    | алкоголизмом,          |        |        |        |        |        |         |        |        |         |
|       | в ремиссии более 2 лет       | находящихся в          |        |        |        |        |        |         |        |        |         |
|       |                              | ремиссии, на 100       |        |        |        |        |        |         |        |        |         |
|       |                              | больных                |        |        |        |        |        |         |        |        |         |
|       |                              | алкоголизмом           |        |        |        |        |        |         |        |        |         |
|       |                              | среднегодового         |        |        |        |        |        |         |        |        |         |
|       |                              | контингента            |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.9   | Доля больных психическими    | процент                |   16,4 | 16,3   | 16,0   | 15,8   | 15,6   | 15,5    | 15,3   | 15,1   | 15,0    |
|       | расстройствами, повторно     |                        |        |        |        |        |        |         |        |        |         |
|       | госпитализированных в        |                        |        |        |        |        |        |         |        |        |         |
|       | течение года                 |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.10  | Доля станций переливания     | процент                |  100,0 | 100,0  | 100,0  | 100,0  | 100,0  | 100,0   | 100,0  | 100,0  | 100,0   |
|       | крови, обеспечивающих        |                        |        |        |        |        |        |         |        |        |         |
|       | современный уровень          |                        |        |        |        |        |        |         |        |        |         |
|       | качества и безопасности      |                        |        |        |        |        |        |         |        |        |         |
|       | компонентов крови            |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.11  | Количество больных,          | чел.                   |   2864 | 3021   | 3325   | 3828   | 4532   | 4922    | 5002   | 5382   | 5728    |
|       | которым оказана              |                        |        |        |        |        |        |         |        |        |         |
|       | высокотехнологичная          |                        |        |        |        |        |        |         |        |        |         |
|       | медицинская помощь           |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.12  | Доля абацилированных         | процент                |   43,5 | 44,0   | 48,0   | 52,5   | 56,9   | 60,0    | 65,0   | 70,0   | 75,0    |
|       | больных туберкулезом от      |                        |        |        |        |        |        |         |        |        |         |
|       | числа больным                |                        |        |        |        |        |        |         |        |        |         |
|       | туберкулезом с               |                        |        |        |        |        |        |         |        |        |         |
|       | бактериовыделением           |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.13  | Доля ВИЧ-инфицированных      | процент                |   17,2 | 18,0   | 19,0   | 21,0   | 21,5   | 21,5    | 22,0   | 23,0   | 23,5    |
|       | лиц, получающих              |                        |        |        |        |        |        |         |        |        |         |
|       | антиретровирусную терапию,   |                        |        |        |        |        |        |         |        |        |         |
|       | от числа состоящих на        |                        |        |        |        |        |        |         |        |        |         |
|       | диспансерном учете           |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.14  | Доля лиц с впервые в жизни   | процент                |    7,9 | 8,6    | 8,5    | 8,4    | 8,3    | 8,2     | 8,0    | 7,9    | 7,8     |
|       | установленным диагнозом      |                        |        |        |        |        |        |         |        |        |         |
|       | активного туберкулеза,       |                        |        |        |        |        |        |         |        |        |         |
|       | находящихся в                |                        |        |        |        |        |        |         |        |        |         |
|       | исправительных учреждениях   |                        |        |        |        |        |        |         |        |        |         |
|       | ФСИН России, от общего       |                        |        |        |        |        |        |         |        |        |         |
|       | числа больных с впервые в    |                        |        |        |        |        |        |         |        |        |         |
|       | жизни установленным          |                        |        |        |        |        |        |         |        |        |         |
|       | диагнозом активного          |                        |        |        |        |        |        |         |        |        |         |
|       | туберкулеза                  |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.15  | Доля лиц с впервые в жизни   | процент                |   13,0 | 12,9   | 12,8   | 12,5   | 12,3   | 12,0    | 11,8   | 11,5   | 11,3    |
|       | установленным диагнозом      |                        |        |        |        |        |        |         |        |        |         |
|       | ВИЧ-инфекции, находящихся    |                        |        |        |        |        |        |         |        |        |         |
|       | в подразделениях ФСИН        |                        |        |        |        |        |        |         |        |        |         |
|       | России, от общего числа      |                        |        |        |        |        |        |         |        |        |         |
|       | больных с впервые в жизни    |                        |        |        |        |        |        |         |        |        |         |
|       | установленным диагнозом      |                        |        |        |        |        |        |         |        |        |         |
|       | ВИЧ-инфекции                 |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 2: совершенствование деятельности скорой, в том числе скорой специализированной, помощи, медицинской эвакуации и организации            |
| оказания медицинской помощи при дорожно-транспортных происшествиях                                                                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.16  | Доля выездов бригад скорой   | процент                |   70,9 | 81,50  | 85,50  | 86,40  | 87,20  | 88,10   | 89,00  | 89,80  | 90,00   |
|       | медицинской помощи со        |                        |        |        |        |        |        |         |        |        |         |
|       | временем доезда до           |                        |        |        |        |        |        |         |        |        |         |
|       | больного менее 20 минут      |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 2.17  | Больничная летальность       | процент                |    5,5 | 5,20   | 5,20   | 5,00   | 5,00   | 4,80    | 4,80   | 4,50   | 4,30    |
|       | пострадавших в результате    |                        |        |        |        |        |        |         |        |        |         |
|       | дорожно-транспортных         |                        |        |        |        |        |        |         |        |        |         |
|       | происшествий                 |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Подпрограмма 3. Государственно-частное партнерство в сфере здравоохранения                                                                       |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 1: развитие конкурентной среды в сфере здравоохранения, в том числе в рамках реализации Программы государственных гарантий              |
| оказания гражданам Российской Федерации бесплатной медицинской помощи                                                                            |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1   | Количество частных           | ед.                    |        | 27,00  | 28,00  | 29,00  | 30,00  | 33,00   | 35,00  | 38,00  | 40,00   |
|       | медицинских организаций в    |                        |        |        |        |        |        |         |        |        |         |
|       | территориальной программе    |                        |        |        |        |        |        |         |        |        |         |
|       | государственных гарантий     |                        |        |        |        |        |        |         |        |        |         |
|       | оказания бесплатной          |                        |        |        |        |        |        |         |        |        |         |
|       | медицинской помощи           |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 2: создание необходимых условий для сохранения здоровья населения республики путем сотрудничества государственных и частных             |
| структур                                                                                                                                         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.2   | Доля лиц, получивших         | процент                |    100 | 100    | 100    | 100    | 100    | 100     | 100    | 100    | 100     |
|       | амбулаторный диализ, от      |                        |        |        |        |        |        |         |        |        |         |
|       | числа нуждавшихся            |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Подпрограмма 4. Охрана здоровья матери и ребенка                                                                                                 |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 1: повышение доступности и качества специализированной медицинской помощи матерям и детям                                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.1   | Смертность детей 0-17 лет    | случаев на 10000       |   11,8 | 11,7   | 11,6   | 11,3   | 11,2   | 11,0    | 10,5   | 10,2   | 10,0    |
|       |                              | населения              |        |        |        |        |        |         |        |        |         |
|       |                              | соответствующего       |        |        |        |        |        |         |        |        |         |
|       |                              | возраста               |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.2   | Выживаемость детей,          | доля (промилле)        |   57,8 | 62,0   | 65,0   | 67,0   | 70,0   | 72,0    | 75,0   | 77,0   | 80,0    |
|       | имевших при рождении очень   | выживших от числа      |        |        |        |        |        |         |        |        |         |
|       | низкую и экстремально        | новорожденных,         |        |        |        |        |        |         |        |        |         |
|       | низкую массу тела, в         | родившихся с низкой    |        |        |        |        |        |         |        |        |         |
|       | акушерском стационаре        | и экстремально         |        |        |        |        |        |         |        |        |         |
|       |                              | низкой массой тела, в  |        |        |        |        |        |         |        |        |         |
|       |                              | акушерском             |        |        |        |        |        |         |        |        |         |
|       |                              | стационаре             |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.3   | Больничная летальность       | доля (процент)         |   0,25 | 0,25   | 0,25   | 0,20   | 0,20   | 0,18    | 0,15   | 0,10   | 0,10    |
|       | детей                        | умерших детей от       |        |        |        |        |        |         |        |        |         |
|       |                              | числа поступивших      |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.4   | Показатель ранней            | случаев на 1000        |   2,76 | 2,75   | 2,70   | 2,68   | 2,65   | 2,60    | 2,58   | 2,50   | 2,50    |
|       | неонатальной смертности      | родившихся живыми      |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.5   | Охват пар "мать - дитя"      | процент                |   85,0 | 85,1   | 85,3   | 85,5   | 85,6   | 85,7    | 85,8   | 85,9   | 85,9    |
|       | химиопрофилактикой в         |                        |        |        |        |        |        |         |        |        |         |
|       | соответствии с               |                        |        |        |        |        |        |         |        |        |         |
|       | действующими стандартами     |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.6   | Число абортов (на 1000       | единиц                 |   31,6 | 31,5   | 31,4   | 30,5   | 29,5   | 28,4    | 27,5   | 27,2   | 26,9    |
|       | женщин в возрасте 15-49 лет) |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 2: совершенствование пренатальной и неонатальной диагностики, неонатальной и фетальной хирургии                                         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.7   | Доля обследованных           | процент                |  67,50 | 66,00  | 66,00  | 66,50  | 66,80  | 67,00   | 68,00  | 69,00  | 70,00   |
|       | беременных женщин по         |                        |        |        |        |        |        |         |        |        |         |
|       | новому алгоритму             |                        |        |        |        |        |        |         |        |        |         |
|       | проведения комплексной       |                        |        |        |        |        |        |         |        |        |         |
|       | пренатальной (дородовой)     |                        |        |        |        |        |        |         |        |        |         |
|       | диагностики нарушений        |                        |        |        |        |        |        |         |        |        |         |
|       | развития ребенка от числа    |                        |        |        |        |        |        |         |        |        |         |
|       | поставленных на учет в       |                        |        |        |        |        |        |         |        |        |         |
|       | первый триместр              |                        |        |        |        |        |        |         |        |        |         |
|       | беременности                 |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.8   | Охват неонатальным           | доля (процент)         |  99,70 | 99,75  | 99,80  | 99,80  | 99,80  | 99,80   | 99,80  | 99,80  | 99,80   |
|       | скринингом                   | новорожденных,         |        |        |        |        |        |         |        |        |         |
|       |                              | обследованных на       |        |        |        |        |        |         |        |        |         |
|       |                              | наследственные         |        |        |        |        |        |         |        |        |         |
|       |                              | заболевания, от        |        |        |        |        |        |         |        |        |         |
|       |                              | общего числа           |        |        |        |        |        |         |        |        |         |
|       |                              | новорожденных          |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 4.9   | Охват аудиологическим        | доля (процент)         |  97,00 | 97,50  | 98,00  | 98,50  | 98,50  | 99,00   | 99,00  | 99,00  | 99,00   |
|       | скринингом                   | новорожденных,         |        |        |        |        |        |         |        |        |         |
|       |                              | обследованных на       |        |        |        |        |        |         |        |        |         |
|       |                              | аудиологический        |        |        |        |        |        |         |        |        |         |
|       |                              | скрининг, от общего    |        |        |        |        |        |         |        |        |         |
|       |                              | числа новорожденных    |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Подпрограмма 5. Развитие медицинской реабилитации и санаторно-курортного лечения                                                                 |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 1: внедрение новых организационных моделей, поддержка развития инфраструктуры системы медицинской реабилитации                          |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 5.1   | Охват реабилитационной       | процент                |   3,50 | 5,50   | 7,50   | 9,00   | 12,00  | 15,00   | 18,50  | 21,50  | 23,00   |
|       | медицинской помощью          |                        |        |        |        |        |        |         |        |        |         |
|       | пациентов                    |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 5.2   | Охват реабилитационной       | процент                |  70,00 | 71,00  | 72,00  | 74,00  | 75,00  | 76,00   | 80,00  | 82,00  | 85,00   |
|       | медицинской помощью          |                        |        |        |        |        |        |         |        |        |         |
|       | детей-инвалидов от числа     |                        |        |        |        |        |        |         |        |        |         |
|       | нуждающихся                  |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 2: внедрение новых организационных моделей, поддержка развития инфраструктуры системы санаторно-курортного лечения                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 5.3   | Охват санаторно-курортным    | процент                |   4,00 | 6,00   | 7,00   | 9,00   | 10,00  | 12,00   | 16,00  | 18,00  | 20,00   |
|       | лечением пациентов           |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 5.4   | Количество койко-мест в      | процент                |    0,5 | 0,5    | 0,6    | 0,6    | 0,7    | 0,7     | 0,8    | 0,9    | 1,0     |
|       | санаторно-курортных          |                        |        |        |        |        |        |         |        |        |         |
|       | организациях                 |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Подпрограмма 6. Паллиативная медицинская помощь                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 1: создание эффективной службы паллиативной помощи неизлечимым больным                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 6.1   | Обеспеченность койками для   | коек/100 тыс.          |   0,20 | 2,98   | 3,55   | 4,29   | 4,30   | 4,31    | 4,33   | 4,36   | 4,36    |
|       | оказания паллиативной        | взрослого населения    |        |        |        |        |        |         |        |        |         |
|       | помощи взрослым              |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 6.2   | Обеспеченность койками для   | коек/100 тыс. детского |  0,128 | 0,128  | 0,128  | 0,128  | 0,21   | 0,21    | 0,21   | 0,21   | 0,21    |
|       | оказания паллиативной        | населения              |        |        |        |        |        |         |        |        |         |
|       | помощи детям                 |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Подпрограмма 7. Кадровое обеспечение системы здравоохранения                                                                                     |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 1: устранение дефицита медицинских кадров                                                                                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 7.1   | Количество подготовленных    | чел.                   |  139,0 | 157,0  | 141,0  | 164,0  | 165,0  | 167,0   | 167,0  | 170,0  | 172,0   |
|       | специалистов по программам   |                        |        |        |        |        |        |         |        |        |         |
|       | дополнительного              |                        |        |        |        |        |        |         |        |        |         |
|       | медицинского и               |                        |        |        |        |        |        |         |        |        |         |
|       | фармацевтического            |                        |        |        |        |        |        |         |        |        |         |
|       | образования в                |                        |        |        |        |        |        |         |        |        |         |
|       | государственных              |                        |        |        |        |        |        |         |        |        |         |
|       | образовательных              |                        |        |        |        |        |        |         |        |        |         |
|       | учреждениях                  |                        |        |        |        |        |        |         |        |        |         |
|       | дополнительного              |                        |        |        |        |        |        |         |        |        |         |
|       | профессионального            |                        |        |        |        |        |        |         |        |        |         |
|       | образования                  |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 7.2   | Количество подготовленных    | чел.                   |   96,0 | 100,0  | 115,0  | 115,0  | 120,0  | 120,0   | 125,0  | 125,0  | 130,0   |
|       | специалистов по программам   |                        |        |        |        |        |        |         |        |        |         |
|       | послевузовского              |                        |        |        |        |        |        |         |        |        |         |
|       | медицинского и               |                        |        |        |        |        |        |         |        |        |         |
|       | фармацевтического            |                        |        |        |        |        |        |         |        |        |         |
|       | образования в                |                        |        |        |        |        |        |         |        |        |         |
|       | государственных              |                        |        |        |        |        |        |         |        |        |         |
|       | образовательных              |                        |        |        |        |        |        |         |        |        |         |
|       | учреждениях                  |                        |        |        |        |        |        |         |        |        |         |
|       | дополнительного              |                        |        |        |        |        |        |         |        |        |         |
|       | профессионального            |                        |        |        |        |        |        |         |        |        |         |
|       | образования                  |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 7.3   | Количество подготовленных    | чел.                   |  455,0 | 558,0  | 499,0  | 579,0  | 400,0  | 592,0   | 500,0  | 600,0  | 492,0   |
|       | специалистов по программам   |                        |        |        |        |        |        |         |        |        |         |
|       | дополнительного              |                        |        |        |        |        |        |         |        |        |         |
|       | медицинского и               |                        |        |        |        |        |        |         |        |        |         |
|       | фармацевтического            |                        |        |        |        |        |        |         |        |        |         |
|       | образования в                |                        |        |        |        |        |        |         |        |        |         |
|       | государственных              |                        |        |        |        |        |        |         |        |        |         |
|       | образовательных              |                        |        |        |        |        |        |         |        |        |         |
|       | учреждениях высшего          |                        |        |        |        |        |        |         |        |        |         |
|       | профессионального            |                        |        |        |        |        |        |         |        |        |         |
|       | образования                  |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 7.4   | Количество подготовленных    | чел.                   | 2672,0 | 2680,0 | 2690,0 | 2700,0 | 2705,0 | 2710,0  | 2715,0 | 2718,0 | 2720,0  |
|       | специалистов по программам   |                        |        |        |        |        |        |         |        |        |         |
|       | дополнительного              |                        |        |        |        |        |        |         |        |        |         |
|       | медицинского и               |                        |        |        |        |        |        |         |        |        |         |
|       | фармацевтического            |                        |        |        |        |        |        |         |        |        |         |
|       | образования в                |                        |        |        |        |        |        |         |        |        |         |
|       | государственных              |                        |        |        |        |        |        |         |        |        |         |
|       | образовательных              |                        |        |        |        |        |        |         |        |        |         |
|       | учреждениях среднего         |                        |        |        |        |        |        |         |        |        |         |
|       | профессионального            |                        |        |        |        |        |        |         |        |        |         |
|       | образования                  |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 7.5   | Доля медицинских и           | процент                |   68,0 | 75,0   | 80,0   | 85,0   | 90,0   | 95,0    | 100,0  | 100,0  | 100,0   |
|       | фармацевтических             |                        |        |        |        |        |        |         |        |        |         |
|       | специалистов, обучавшихся в  |                        |        |        |        |        |        |         |        |        |         |
|       | рамках целевой подготовки    |                        |        |        |        |        |        |         |        |        |         |
|       | для нужд соответствующего    |                        |        |        |        |        |        |         |        |        |         |
|       | субъекта Российской          |                        |        |        |        |        |        |         |        |        |         |
|       | Федерации,                   |                        |        |        |        |        |        |         |        |        |         |
|       | трудоустроившихся после      |                        |        |        |        |        |        |         |        |        |         |
|       | завершения обучения в        |                        |        |        |        |        |        |         |        |        |         |
|       | медицинские или              |                        |        |        |        |        |        |         |        |        |         |
|       | фармацевтические             |                        |        |        |        |        |        |         |        |        |         |
|       | организации системы          |                        |        |        |        |        |        |         |        |        |         |
|       | здравоохранения              |                        |        |        |        |        |        |         |        |        |         |
|       | соответствующего субъекта    |                        |        |        |        |        |        |         |        |        |         |
|       | Российской Федерации         |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 2: совершенствование системы подготовки специалистов и создание условий для планомерного роста профессионального уровня знаний          |
| и умений медицинских работников                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 7.6   | Количество обучающихся,      | чел.                   |    9,0 | 10,0   | 15,0   | 15,0   | 50,0   | 60,0    | 70,0   | 90,0   | 100,0   |
|       | прошедших подготовку в       |                        |        |        |        |        |        |         |        |        |         |
|       | обучающих симуляционных      |                        |        |        |        |        |        |         |        |        |         |
|       | центрах                      |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 7.7   | Доля аккредитованных         | процент                |      0 | 0      | 0      | 0      | 0      | 20,0    | 40,0   | 60,0   | 80,0    |
|       | специалистов                 |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Подпрограмма 8. Лекарственное обеспечение                                                                                                        |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 1: совершенствование механизмов обеспечения отдельных категорий граждан необходимыми качественными лекарственными                       |
| препаратами, изделиями медицинского назначения и специализированными продуктами питания                                                          |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 8.1   | Удовлетворение потребности   | процент                |   94,0 | 94,5   | 95,0   | 95,5   | 96,0   | 96,5    | 97,0   | 97,5   | 98,00   |
|       | отдельных категорий          |                        |        |        |        |        |        |         |        |        |         |
|       | граждан в необходимых        |                        |        |        |        |        |        |         |        |        |         |
|       | лекарственных препаратах и   |                        |        |        |        |        |        |         |        |        |         |
|       | медицинских изделиях, а      |                        |        |        |        |        |        |         |        |        |         |
|       | также специализированных     |                        |        |        |        |        |        |         |        |        |         |
|       | продуктах лечебного питания  |                        |        |        |        |        |        |         |        |        |         |
|       | для детей-инвалидов (от      |                        |        |        |        |        |        |         |        |        |         |
|       | числа лиц, имеющих право     |                        |        |        |        |        |        |         |        |        |         |
|       | на государственную           |                        |        |        |        |        |        |         |        |        |         |
|       | социальную помощь и не       |                        |        |        |        |        |        |         |        |        |         |
|       | отказавшихся от получения    |                        |        |        |        |        |        |         |        |        |         |
|       | социальной услуги            |                        |        |        |        |        |        |         |        |        |         |
|       | лекарственными               |                        |        |        |        |        |        |         |        |        |         |
|       | препаратами, изделиями       |                        |        |        |        |        |        |         |        |        |         |
|       | медицинского назначения, а   |                        |        |        |        |        |        |         |        |        |         |
|       | также специализированными    |                        |        |        |        |        |        |         |        |        |         |
|       | продуктами лечебного         |                        |        |        |        |        |        |         |        |        |         |
|       | питания для                  |                        |        |        |        |        |        |         |        |        |         |
|       | детей-инвалидов)             |                        |        |        |        |        |        |         |        |        |         |
|-------+------------------------------+------------------------+--------+--------+--------+--------+--------+---------+--------+--------+---------|
| 8.2   | Удовлетворение спроса на     | процент                |   97,0 | 97,2   | 98,0   | 98,2   | 98,3   | 98,4    | 98,5   | 98,6   | 98,8    |
|       | лекарственные препараты,     |                        |        |        |        |        |        |         |        |        |         |
|       | предназначенные для          |                        |        |        |        |        |        |         |        |        |         |
|       | лечения больных              |                        |        |        |        |        |        |         |        |        |         |
|       | злокачественными             |                        |        |        |        |        |        |         |        |        |         |
|       | новообразованиями            |                        |        |        |        |        |        |         |        |        |         |
|       | лимфоидной, кроветворной и   |                        |        |        |        |        |        |         |        |        |         |
|       | родственных им тканей,       |                        |        |        |        |        |        |         |        |        |         |
|       | гемофилией,                  |                        |        |        |        |        |        |         |        |        |         |
|       | муковисцидозом,              |                        |        |        |        |        |        |         |        |        |         |
|       | гипофизарным нанизмом,       |                        |        |        |        |        |        |         |        |        |         |
|       | болезнью Гоше, рассеянным    |                        |        |        |        |        |        |         |        |        |         |
|       | склерозом, а также после     |                        |        |        |        |        |        |         |        |        |         |
|       | трансплантации органов и     |                        |        |        |        |        |        |         |        |        |         |
|       | (или) тканей (от числа лиц,  |                        |        |        |        |        |        |         |        |        |         |
|       | включенных в Федеральный     |                        |        |        |        |        |        |         |        |        |         |
|       | регистр больных и больных    |                        |        |        |        |        |        |         |        |        |         |
|       | злокачественными             |                        |        |        |        |        |        |         |        |        |         |
|       | новообразованиями            |                        |        |        |        |        |        |         |        |        |         |
|       | лимфоидной, кроветворной и   |                        |        |        |        |        |        |         |        |        |         |
|       | родственных им тканей,       |                        |        |        |        |        |        |         |        |        |         |
|       | гемофилией,                  |                        |        |        |        |        |        |         |        |        |         |
|       | муковисцидозом,              |                        |        |        |        |        |        |         |        |        |         |
|       | гипофизарным нанизмом,       |                        |        |        |        |        |        |         |        |        |         |
|       | болезнью Гоше, рассеянным    |                        |        |        |        |        |        |         |        |        |         |
|       | склерозом, а также после     |                        |        |        |        |        |        |         |        |        |         |
|       | трансплантации органов и     |                        |        |        |        |        |        |         |        |        |         |
|       | (или) тканей)                |                        |        |        |        |        |        |         |        |        |         |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Задача N 2: обеспечение отдельных групп населения и категорий заболеваний, при амбулаторном лечении которых лекарственные препараты и            |
| изделия медицинского назначения отпускаются бесплатно или со скидкой 50%, лиц, страдающих жизнеугрожающими и хроническими                        |
| прогрессирующими редкими (орфанными) заболеваниями, а также обеспечение контроля качества лекарственных препаратов                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 8.3   | Удовлетворенность спроса     | процент                |   91,0 | 92,0   | 93,0   | 94,0   | 94,5   | 95,0    | 97,0   | 97,5   | 98,0    |
|       | на лекарственные препараты,  |                        |        |        |        |        |        |         |        |        |         |